OMEPRAZOLE IS MORE EFFECTIVE THAN CIMETIDINE FOR THE RELIEF OF ALL GRADES OF GASTROESOPHAGEAL REFLUX DISEASE-ASSOCIATED HEARTBURN, IRRESPECTIVE OF THE PRESENCE OR ABSENCE OF ENDOSCOPIC ESOPHAGITIS
Cm. Bate et al., OMEPRAZOLE IS MORE EFFECTIVE THAN CIMETIDINE FOR THE RELIEF OF ALL GRADES OF GASTROESOPHAGEAL REFLUX DISEASE-ASSOCIATED HEARTBURN, IRRESPECTIVE OF THE PRESENCE OR ABSENCE OF ENDOSCOPIC ESOPHAGITIS, Alimentary pharmacology & therapeutics, 11(4), 1997, pp. 755-763
Background: Previous studies have demonstrated greater efficacy for om
eprazole compared with cimetidine in patients with endoscopically veri
fied oesophagitis, but excluded the substantial group of gastro-oesoph
ageal reflux disease (GERD) patients with reflux symptoms but without
endoscopic abnormality. This prospective, randomized, double-blind stu
dy compared omeprazole and cimetidine in the treatment of GERD-associa
ted heartburn both in patients with symptomatic nonulcerative oesophag
itis and in those with heartburn but without oesophagitis. Methods: A
total of 221 patients with heartburn and oesophageal mucosa grade 0 (n
ormal, n = 51), 1 (no macroscopic erosions, n = 52), 2 (isolated erosi
ons, n = 97) or 3 (confluent erosions, n = 21) were randomized to rece
ive double-blind either omeprazole 20 mg daily or cimetidine 400 mg q.
d.s. for a period of 4 weeks. Those still symptomatic after 4 weeks of
treatment received omeprazole 20 mg daily for a further 4 weeks. Resu
lts: There was no correlation between severity of heartburn and endosc
opic grade at entry (correlation coefficient = 0.196). After 4 weeks o
f treatment, the proportion of patients in whom heartburn was controll
ed (no more than mild symptoms on no more than 1 day in the previous 7
) on omeprazole (66%; 74/112) was more than double that on cimetidine
(31%; 34/109) (P < 0.0001). There was no significant difference betwee
n the relief of heartburn in the 47% of patients without unequivocal o
esophagitis (endoscopic grade 0 or 1) and in the 53% of patients with
erosive oesophagitis (grade 2 or 3) (P = 0.31). Only treatment with om
eprazole (P < 0.0001) and lower severity of heartburn at entry (P < 0.
01) were significant in predicting heartburn relief. Amongst those pat
ients requiring an additional 4 weeks of treatment with omeprazole, 67
% (54/81) reported that their heartburn was controlled after 8 weeks o
f treatment. Conclusion: We conclude that omeprazole is superior to ci
metidine for the relief of all grades of heartburn in GERD, whether or
not the patient has unequivocal endoscopic oesophagitis.